203 related articles for article (PubMed ID: 35538191)
1. Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.
Khare P; Chogale MM; Kakade P; Patravale VB
Drug Deliv Transl Res; 2022 Dec; 12(12):2920-2935. PubMed ID: 35538191
[TBL] [Abstract][Full Text] [Related]
2. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
3. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
[TBL] [Abstract][Full Text] [Related]
6. A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin.
Sai N; Dong X; Huang P; You L; Yang C; Liu Y; Wang W; Wu H; Yu Y; Du Y; Leng X; Yin X; Qu C; Ni J
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878332
[TBL] [Abstract][Full Text] [Related]
7. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
Senjoti FG; Timmins P; Conway BR; Smith AM
Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel.
Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A
Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467
[TBL] [Abstract][Full Text] [Related]
9. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
10. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.
Morsi N; Ibrahim M; Refai H; El Sorogy H
Eur J Pharm Sci; 2017 Jun; 104():302-314. PubMed ID: 28433750
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A; González Barcia M; Gil-Martínez M; Vieites-Prado A; Lema I; Argibay B; Blanco Méndez J; Lamas MJ; Otero-Espinar FJ
Eur J Pharm Biopharm; 2015 Aug; 94():342-51. PubMed ID: 26079831
[TBL] [Abstract][Full Text] [Related]
12. Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation.
Bhalerao H; Koteshwara KB; Chandran S
AAPS PharmSciTech; 2020 Jan; 21(2):69. PubMed ID: 31950311
[TBL] [Abstract][Full Text] [Related]
13. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.
Saindane NS; Pagar KP; Vavia PR
AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198
[TBL] [Abstract][Full Text] [Related]
14. Gellan Gum Based
Janga KY; Tatke A; Dudhipala N; Balguri SP; Ibrahim MM; Maria DN; Jablonski MM; Majumdar S
J Pharmacol Exp Ther; 2019 Sep; 370(3):814-822. PubMed ID: 30872389
[TBL] [Abstract][Full Text] [Related]
15. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
[TBL] [Abstract][Full Text] [Related]
16. Effect of gellan gum on the thermogelation property and drug release profile of Poloxamer 407 based ophthalmic formulation.
Dewan M; Sarkar G; Bhowmik M; Das B; Chattoapadhyay AK; Rana D; Chattopadhyay D
Int J Biol Macromol; 2017 Sep; 102():258-265. PubMed ID: 28390828
[TBL] [Abstract][Full Text] [Related]
17. Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis.
Jaiswal M; Kumar M; Pathak K
Colloids Surf B Biointerfaces; 2015 Jun; 130():23-30. PubMed ID: 25889081
[TBL] [Abstract][Full Text] [Related]
18. Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops.
Sultana Y; Aqil M; Ali A
Drug Deliv; 2006; 13(3):215-9. PubMed ID: 16556574
[TBL] [Abstract][Full Text] [Related]
19. L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.
Singh SR; Carreiro ST; Chu J; Prasanna G; Niesman MR; Collette Iii WW; Younis HS; Sartnurak S; Gukasyan HJ
J Pharm Pharmacol; 2009 Jun; 61(6):733-42. PubMed ID: 19505363
[TBL] [Abstract][Full Text] [Related]
20. Gellan gum fluid gels for topical administration of diclofenac.
Mahdi MH; Conway BR; Mills T; Smith AM
Int J Pharm; 2016 Dec; 515(1-2):535-542. PubMed ID: 27789369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
